InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,321.41
(
0.25%
)
US TECH 100
18,244.80
(
0.27%
)
Dow Jones
39,872.99
(
0.17%
)
Brent Oil
82.15
(
-0.36%
)
Bitcoin
69,602.72
(
-0.75%
)
Post# of 251888
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 160604

Wednesday, 05/01/2013 4:48:29 PM

Wednesday, May 01, 2013 4:48:29 PM

Post# of 251888

AGN tested the two highest-tolerated doses from the phase-1

It could be insufficient differentiation from Lucentis on efficacy or duration of time the effect was sustained for, which will translate to injections frequency. Either way, if there was a dose response, they can try an even higher dose to improved one or both parameters. Needless to say I'm not as optimistic as before.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up